Breast cancer

Updated 13 November 2017

Effects of breast implants

Women with breast implants appear to have a higher false-negative mammography rate than the general population.

Women with breast implants appear to have a higher false-negative mammography rate than the general population, according to data presented this week at the annual meeting of the American Society of Breast Surgeons in Washington, DC.

These patients also present more often with palpable and node-positive disease than women without implants, the study shows. Yet there was no difference in cancer recurrence or 10-year survival.

"The take-home message is that if a woman has implants and she's at elevated risk for breast cancer, MRI is suggested in addition to mammography," said Dr Sheldon Feldman, chief of breast surgery at Columbia University Medical Centre in New York and Chair of the society's publication committee.

"I don't think the data are strong enough to make any statements about the prognosis," added Dr Feldman, who was not involved in the new work.

The findings are based on retrospective data on 195 breast cancer patients with breast augmentation and 4,810 without.

The study

Dr Jessica Rayhanabad of the University of Southern California, Los Angeles, and colleagues examined palpability, tumour size, nuclear grade, breast cancer-specific survival and other factors in these patients.

Prebiopsy mammography yielded a false-negative rate of 36% among the augmented patients, compared to only 15% in the general population, Dr Rayhanabad's team found.

One reason for the higher rate might be related to older augmentation methods.

"People used to put the implant above the pectoral muscle," said Dr Rayhanabad. "The actual mammogram was difficult to read. Now that they're putting the implants behind the pec, it's not as challenging to read the mammogram."

But, she added, even new implants still present some difficulty during screening.


In the study, 68% of the augmented patients had palpable cancers, compared to 52% of the patients in the control group (p=0.001). In addition, 46% of the augmented group had node-positive cancer vs. 33% of the control group (p=0.005).

It's possible that the implant pushes breast tissue from behind up against the skin, making cancers easier to palpate, Dr Rayhanabad said. People who seek augmentation may also have less breast tissue, which could make it easier to detect the disease.

She added that she was surprised to see that breast implants had no effect on cancer recurrence, breast-cancer-specific survival or overall survival.

"I did expect to see a difference in the survival rate if there were more patients with node-positive diseases," Dr Rayhanabad said, adding that a larger study might be needed to show an effect.

(Reuters Health, Rob Goodier, May 2011)


Read Health24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Ask the Expert

Breast cancer expert

Dr Gudgeon qualified in Birmingham, England, in 1968. She has more than 40 years experience in oncology, and in 1994 she founded her practice, Cape Breast Care, where she treats benign and malignant breast cancers. Dr Boeddinghaus obtained her qualification at UCT Medical School in 1994 and her MRCP in London in 1998. She has worked extensively in the field of oncology and has a special interest in the hormonal management of breast cancer. She now works with Dr Gudgeon at Cape Breast Care. Read more.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules